Lynparza 100 mg/1

Lynparza 100 mg is a medication used for certain types of cancer treatment. It contains the active ingredient olaparib, a PARP inhibitor. This oral tablet is designed to target specific genetic mutations.

Lynparza 100 mg is primarily used in the treatment of advanced ovarian cancer and certain types of breast cancer. It is often prescribed for patients with specific genetic mutations, such as BRCA mutations. Olaparib works by inhibiting the PARP enzyme, which can help slow the growth of cancer cells. This medication is typically used in patients who have already undergone other treatments.

Common effects of Lynparza 100 mg may include fatigue, nausea, and anemia. Some patients may also experience vomiting, diarrhea, or a decrease in appetite. It is important to discuss any persistent or severe side effects with a healthcare provider.

Lynparza 100 mg should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Lynparza 100 mg may interact with certain medications, including those that affect liver enzymes. It is important to discuss all current medications with a healthcare provider before starting olaparib. Alcohol and other substances may also interact with this medication, so it is advisable to consult a healthcare professional for personalized advice.